isomethyleugenol has been researched along with Carotid Arteriopathies, Traumatic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ai, D; Cai, W; Jiang, S; Li, Q; Li, X; Liang, J; Song, H; Tian, S; Wang, C; Yang, B; Zhang, K; Zhang, X; Zhu, Y | 1 |
| Chen, J; Hu, Q; Jiang, H; Xu, C; Xu, L; Yang, J; Yang, S; Zhang, J | 1 |
| Berka, V; Cardounel, AJ; Cui, H; Johnson, W; Kearns, P; Samouilov, A; Tsai, AL; Zweier, JL | 1 |
3 other study(ies) available for isomethyleugenol and Carotid Arteriopathies, Traumatic
| Article | Year |
|---|---|
Inhibition of polycomb repressor complex 2 ameliorates neointimal hyperplasia by suppressing trimethylation of H3K27 in vascular smooth muscle cells.
Topics: Animals; Becaplermin; Carotid Artery Injuries; Cell Cycle; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; Histones; Humans; Hyperplasia; Male; Methylation; Muscle, Smooth, Vascular; Neointima; Polycomb Repressive Complex 2; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2019 |
Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats.
Topics: Animals; Carotid Arteries; Carotid Artery Injuries; Cell Proliferation; Diabetes Mellitus, Experimental; Gene Expression Regulation; HEK293 Cells; Histone Demethylases; Histones; Humans; Hyperplasia; Jumonji Domain-Containing Histone Demethylases; Male; Methylation; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Promoter Regions, Genetic; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; rho-Associated Kinases; RNA Interference; Signal Transduction; Time Factors; Transcription, Genetic; Transfection | 2017 |
Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function.
Topics: Animals; Aorta; Arginine; Carotid Artery Injuries; Catheterization; Cattle; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Humans; Kinetics; Male; Methylation; Nitric Oxide; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Rats; Rats, Wistar; Vasodilation | 2007 |